Vallabhaneni Vasudha MD Bridgeport, CT - 06606

Vallabhaneni Vasudha MD is categorized under Internal Medicine Practitioners in Bridgeport, CT and active since 2011.

Vallabhaneni Vasudha MD was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Vasudha Vallabhaneni at the company’s single location by writing to 3180 Main St # 301, Bridgeport, Connecticut CT 06606 or by phoning (203) 373-9100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Vallabhaneni Vasudha MD
Contact Person: Vasudha Vallabhaneni
Address: 3180 Main St # 301, Bridgeport, Connecticut 06606
Phone Number: (203) 373-9100
Annual Revenue (USD): $500.000 to $999.999
Founded: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Vallabhaneni Vasudha MD was started in 2011 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Vasudha Vallabhaneni for inquiries that concern Vallabhaneni Vasudha MD by calling the company number (203) 373-9100, as your correspondence is most welcome. Additionally, the physical location of the single location of Vallabhaneni Vasudha MD can be found at the coordinates 41.205311,-73.205588 as well as the street address 3180 Main St # 301 in Bridgeport, Connecticut 06606.

For its online presence, you may visit Vallabhaneni Vasudha MD’s website at and engage with its social media outlets through on Twitter and on Facebook.